KalshiScience and Technology

When will Intellia Therapeutics submit a BLA for Lonvo-z?

Lonvoguran Ziclumeran (lonvo-z) - BLA

Ends Sep 1, 2026

Disclosure

18+ only. Event contracts carry significant risk and are not suitable for everyone, you can lose the entire amount you commit. Not available in all jurisdictions; restrictions and eligibility requirements apply.

Probability

before September1.9K VOL.
Yes 5%No 95%
5¢
before October8.2K VOL.
Yes 98%No 2%
98¢
before November4.9K VOL.
Yes 91%No 9%
91¢
before December1.3K VOL.
Yes 96%No 4%
96¢
before 20272.1K VOL.
Yes 98%No 2%
98¢

Rules Summary

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Sep 1, 2026, then the market resolves to Yes.

Timeline and Payout

Opened: Mar 24, 2026, 2:00 PM
Closes: Sep 1, 2026, 2:00 PM
Pays out: 0.5 hours after close

Series KXNEWDRUGAPPNTLA · Event KXNEWDRUGAPPNTLA-LONV · Market KXNEWDRUGAPPNTLA-LONV-26SEP01